Impact of copper deficiency in humans

Annals of the New York Academy of Sciences

Volumn 1314, Issue 1, 2014, Pages 1-5

  Prohaska, Joseph R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

CCS; Copper deficiency; Cuproenzymes; Humans

Indexed keywords

BIOLOGICAL MARKER; COPPER;

ARTICLE; ATAXIA; BARIATRIC SURGERY; CLINICAL FEATURE; COPPER DEFICIENCY; DIET; HUMAN; IRON DEFICIENCY ANEMIA; MALABSORPTION; OBESITY; PANCYTOPENIA; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; RISK FACTOR; SCREENING;

CCS; COPPER DEFICIENCY; CUPROENZYMES; HUMANS;

ANEMIA, HYPOCHROMIC; BIOLOGICAL MARKERS; COPPER; DIET; HUMANS; METAL METABOLISM, INBORN ERRORS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 84900013218     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12354     Document Type: Article

References (34)

1. Fox, P.L. 2003. The copper-iron chronicles: the story of an intimate relationship. Biometals 16: 9-40.
2. Chambers, A. et al. 2010. An exposure-response curve for copper excess and deficiency. J. Toxicol. Environ. Health. 13: 546-578.
3. Mejia-Rodriguez, F. et al. 2013. Iron, zinc, copper and magnesium deficiencies in Mexican adults from the National Health and Nutrition Survey 2006. Salud Publica Mex. 55: 275-284.
4. Prohaska, J.R. & B. Brokate . 2002. The timing of perinatal copper deficiency in mice influences offspring survival. J. Nutr. 132: 3142-3145.
5. Gletsu-Miller, N. & B.N. Wright . 2013. Mineral malnutrition following bariatric surgery. Adv. Nutr. 4: 506-517.
6. Rojas, P. et al. 2011. Trace element status and inflammation parameters after 6 months of Roux-en-Y gastric bypass. Obes. Surg. 21: 561-568.
7. Gletsu-Miller, N. et al. 2012. Incidence and prevalence of copper deficiency following roux-en-y gastric bypass surgery. Int. J. Obes. (Lond.) 36: 328-335.
8. Mechanick, J.I. et al. 2013. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity 21(Suppl. 1): S1-S27.
9. Nations, S.P. et al. 2008. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology 71: 639-643.
10. Greenberg, S.A. & H.R. Briemberg . 2004. A neurological and hematological syndrome associated with zinc excess and copper deficiency. J. Neurol. 251: 111-114.
11. Cortese, A. et al. 2011. Copper deficiency in Wilson's disease: peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment. Mov. Disord. 26: 1361-1362.
12. Goez, H.R. et al. 2011. An unusual presentation of copper metabolism disorder and a possible connection with Niemann-Pick type C. J. Child Neurol. 26: 518-521.
13. Fox, J.H. et al. 2007. Mechanisms of copper ion mediated Huntington's disease progression. PLoS One 2: e334.
14. Underwood, E.J. 1971. "Copper." In Trace Elements in Human and Animal Nutrition: 57-115. W. Mertz, Ed. New York, NY: Academic Press.
15. Prohaska, J.R. 2012. "Copper." In Present Knowledge in Nutrition. J. Erdman, I. Macdonald & S. Zeisel, Eds.: 873-896. Oxford, UK: Wiley-Blackwell.
16. Danks, D.M. 1988. Copper deficiency in humans. Annu. Rev. Nutr. 8: 235-257.
17. Prohaska, J.R. 2011. Impact of copper limitation on expression and function of multicopper oxidases (ferroxidases). Adv. Nutr. 2: 129-137.
18. Morita, H. et al. 1995. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann. Neurol. 37: 646-656.
19. Kumar, N. et al. 2004. Copper deficiency myelopathy. Arch. Neurol. 61: 762-766.
20. Mostad, E.J. & J.R. Prohaska . 2011. Glycosylphosphatidylinositol-linked ceruloplasmin is expressed in multiple rodent organs and is lower following dietary copper deficiency. Exp. Biol. Med. 236: 298-308.
21. Bousquet-Moore, D. et al. 2009. Reversal of physiological deficits caused by diminished levels of peptidylglycine alpha-amidating monooxygenase by dietary copper. Endocrinology 150: 1739-1747.
22. Dembinski, K. et al. 2012. Three distinct cases of copper deficiency in hospitalized pediatric patients. Clin. Pediatr. (Phila) 51: 759-762.
23. Lutsenko, S. 2010. Human copper homeostasis: a network of interconnected pathways. Curr. Opin. Chem. Biol. 14: 211-217.
24. Kennerson, M.L. et al. 2010. Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. Am. J. Hum. Genet. 86: 343-352.
25. Turski, M.L. et al. 2012. A novel role for copper in Ras/mitogen-activated protein kinase signaling. Mol. Cell Biol. 32: 1284-1295.
26. Harvey, L.J. et al. 2009. Methods of assessment of copper status in humans: a systematic review. Am. J. Clin. Nutr. 89: 2009S-2024S.
27. Bertinato, J. & A. Zouzoulas . 2009. Considerations in the development of biomarkers of copper status. J. AOAC Int. 92: 1541-1550.
28. Prohaska, J.R., M. Broderius & B. Brokate . 2003. Metallochaperone for Cu, Zn-superoxide dismutase (CCS) protein but not mRNA is higher in organs from copper-deficient mice and rats. Arch. Biochem. Biophys. 417: 227-234.
29. West, E.C. & J.R. Prohaska . 2004. Cu, Zn-superoxide dismutase is lower and copper chaperone CCS is higher in erythrocytes of copper-deficient rats and mice. Exp. Biol. Med. 229: 756-764.
30. Lassi, K.C. & J.R. Prohaska . 2011. Rapid alteration in rat red blood cell copper chaperone for superoxide dismutase after marginal copper deficiency and repletion. Nutr. Res. 31: 698-706.
31. Lassi, K.C. & J.R. Prohaska . 2012. Erythrocyte copper chaperone for superoxide dismutase is increased following marginal copper deficiency in adult and postweanling mice. J. Nutr. 142: 292-297.
32. Suazo, M. et al. 2008. CCS and SOD1 mRNA are reduced after copper supplementation in peripheral mononuclear cells of individuals with high serum ceruloplasmin concentration. J. Nutr. Biochem. 19: 269-274.
33. Robinson, S.D., B. Cooper & T.V. Leday . 2013. Copper deficiency (hypocupremia) and pancytopenia late after gastric bypass surgery. Proc. (Bayl. Univ. Med. Cent.) 26: 382-386.
34. Singh, I. et al. 2013. Low levels of copper disrupt brain amyloid-beta homeostasis by altering its production and clearance. Proc. Natl. Acad. Sci. U. S. A. 110: 14771-14776.